Gut Microbiota Profiles in Diarrhea-Predominant Irritable Bowel Syndrome and Their Relationship to Clinical Efficacy of Hangeshashinto: The GMIBS-HA Study
Journal of the Anus, Rectum and Colon · 25.10.2026 · 10 (4) · 605-614
DOI: 10.23922/jarc.2026-037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Anus, Rectum and Colon, erschienen am 25.10.2026. Verfasst von Naohisa Yoshida und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Objectives
This study aimed to identify specific microbiota associated with diarrhea-predominant irritable bowel syndrome (IBS-D) and to evaluate clinical improvement in IBS-D according to changes in gut microbiota abundance following treatment with Hangeshashinto (HST), an anti-inflammatory Kampo medicine.
Methods
This post-hoc retrospective analysis included 20 IBS-D patients from a previous study in whom gut microbiota had been analyzed. Patients were enrolled at two affiliated institutions between March and December 2023 and received HST 7.5 g/day for 2-3 weeks. Gut microbiota of IBS-D patients were compared with those of 20 age- and sex-matched healthy controls. Differences in microbiota before and after HST administration between effective and non-effective cases were also analyzed.
Results
Compared with healthy controls, IBS-D patients showed significant differences in alpha diversity (Faith's PD, p=0.016) and beta diversity (unweighted p=0.006; weighted p=0.031). Taxonomic analysis demonstrated increased Escherichia-Shigella (p=0.003, q (Benjamini-Hochberg false discovery rate correction)=0.035) and decreased Faecalibacterium (p=0.005, q=0.035). In the comparison of pre-HST microbiota between 14 effective and 6 non-effective cases, significant increase of Escherichia-Shigella (p
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular Gastroenterology and Hepatology, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
- Department of Gastroenterology, Nishijin Hospital, Kyoto, Japan.
- Department of Gastroenterology, Hakuaikai Hospital, Kyoto, Japan.
- Department of Infectious Disease, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.
Zitieren
APA
Yoshida, N., Yasuda, T., Inagaki, Y., Tomita, Y., Hirose, R., Kobayashi, R., Iwai, N., Inoue, K., Dohi, O., Uchiyama, K., & Takagi, T. (2026). Gut Microbiota Profiles in Diarrhea-Predominant Irritable Bowel Syndrome and Their Relationship to Clinical Efficacy of Hangeshashinto: The GMIBS-HA Study. Journal of the Anus, Rectum and Colon, 10(4), 605-614. https://doi.org/10.23922/jarc.2026-037
Vancouver
Yoshida N, Yasuda T, Inagaki Y, Tomita Y, Hirose R, Kobayashi R, et al. Gut Microbiota Profiles in Diarrhea-Predominant Irritable Bowel Syndrome and Their Relationship to Clinical Efficacy of Hangeshashinto: The GMIBS-HA Study. Journal of the Anus, Rectum and Colon. 2026;10(4):605-614. doi:10.23922/jarc.2026-037
BibTeX
@article{Yoshida2026,
author = {Yoshida, Naohisa and Yasuda, Takeshi and Inagaki, Yoshikazu and Tomita, Yuri and Hirose, Ryohei and Kobayashi, Reo and Iwai, Naoto and Inoue, Ken and Dohi, Osamu and Uchiyama, Kazuhiko and Takagi, Tomohisa},
title = {Gut Microbiota Profiles in Diarrhea-Predominant Irritable Bowel Syndrome and Their Relationship to Clinical Efficacy of Hangeshashinto: The GMIBS-HA Study},
journal = {Journal of the Anus, Rectum and Colon},
year = {2026},
volume = {10},
number = {4},
pages = {605--614},
doi = {10.23922/jarc.2026-037}
}
EUVIMED